To accelerate our endeavors to overcome cancer, Chinese Journal of Cancer has launched a program of publishing 150 most important questions in cancer research and clinical oncology. In this article, 6 more questions are presented as followed. Question 25: Does imprinting of immune responses to infections early in life predict future risk of childhood and adult cancers? Question 26: How to induce homogeneous tumor antigen expression in a heterogeneous tumor mass to enhance the efficacy of cancer immunotherapy? Question 27: Could we enhance the therapeutic effects of immunotherapy by targeting multiple tumor antigens simultaneously or sequentially? Question 28: Can immunotargeting to cytokines halt cancer metastasis? Question 29: How can we dynamically and less-invasively monitor the activity of CD8(+) T killer cells at tumor sites and draining lymph nodes? Question 30: How can the immune system destroy the niches for cancer initiation?
语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2017]版：
大类|3 区医学
小类|3 区肿瘤学
最新[2023]版：
无
第一作者：
第一作者机构：[2]NCI, Bethesda, MD 20892 USA;
通讯作者：
通讯机构：[2]NCI, Bethesda, MD 20892 USA;
推荐引用方式(GB/T 7714)：
Hildesheim Allan,Xia Xiaojun,Li Xinjian,et al.The 150 most important questions in cancer research and clinical oncology series: Questions 25-30[J].CHINESE JOURNAL OF CANCER.2017,36(1):-.doi:10.1186/s40880-017-0210-y.
APA：
Hildesheim, Allan,Xia, Xiaojun,Li, Xinjian,Yan, Li&Krishnatreya, Manigreeva.(2017).The 150 most important questions in cancer research and clinical oncology series: Questions 25-30.CHINESE JOURNAL OF CANCER,36,(1)
MLA：
Hildesheim, Allan,et al."The 150 most important questions in cancer research and clinical oncology series: Questions 25-30".CHINESE JOURNAL OF CANCER 36..1(2017):-
